Navigation Links
ACORN Expands Oncology Information Portfolio With Comprehensive Data Warehouse

MEMPHIS, Tenn., May 27 /PRNewswire/ -- Accelerated Community Oncology Research Network(TM) (ACORN), an oncology-focused CRO and research network, announced today its expansion of the company's aggregated information portfolio with a proprietary oncology-focused data warehouse. Integrating patient-reported outcomes (PROs), electronic medical records (EMR), claims data, and laboratory information systems, garnered from community oncology practices nationwide where 85% of cancer care is provided, ACORN's unique data warehouse offers reliable information solutions to payers, financial institutions, pharmaceutical / biotech companies, and community oncology practices.

(Logo: )

With the recent announcement of the company's accrual of over one million comprehensive physical and psychological cancer patient assessments obtained via the Patient Assessment Care and Education (PACE) System PACE(TM) and continued market uptake of Guardian EDC(TM) (web-based electronic data capture), ACORN(TM) continues to demonstrate leadership in capturing unique electronic data into a single platform for easy access across the full range of data elements and conducting scientific analysis to generate reliable information solutions in the oncology industry.

According to CEO, Steve Coplon, "We are not just the purveyors of data; we analyze it, and provide solutions through our multimodal capabilities. Our national network of oncologists, nurses, and practice administrators works closely with our PhD statisticians, psychologists, and health economists on staff to conduct unique analysis which has been well received across multiple industries. ACORN's data warehouse has reached critical mass in that it now provides a representative sample of most cancer types and treatment regimens. Many pharmaceutical, biotech, insurance companies, and others have been pleased with our ability to answer important questions on a whole array of cancer and quality of life issues. This is achieved by having a diverse and full complement of reliable data sets that are assessed and analyzed by our experienced scientific team."

ACORN's unique data warehouse enables pharmacoeconomic and health outcomes analysis previously unachievable. "In addition to traditional sources of information, we have a unique component in our PACE PRO gathering capability which allows us to scientifically analyze patients' symptom burden and quality of life," states Mark Walker, PhD, Director of Scientific Management. "Historically, the analysis of treatments and outcomes, either clinical or economic across different patient populations, has not included rigorous measurements of patient-reported outcomes, both physical and psychological. In addition, Pharma and payer sectors are finding increased value from ACORN's immediate access to hundreds of thousands of oncology patients."

Analytical results are routinely published in peer-reviewed journals and presented at major scientific meetings. For additional information visit or contact Liz Conway, Director of Marketing and Corporate Services, 901-259-0878.

Accelerated Community Oncology Research Network, Inc. (ACORN) ACORN focuses on oncology exclusively. ACORN offers centralized clinical trial services, scientific analysis, and is a full-service Clinical Research Organization (CRO), providing contract and budgeting services; fostering accrual of subjects at the site level; collecting data and monitoring its accuracy; and working seamlessly with both trial sponsors and participating practices.

Contact Information:

Liz Conway

(901) 435-5570

Deborah D. Coble


Cell: 901-831-1010

SOURCE Accelerated Community Oncology Research Network
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx
2. Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc.
3. DuPont Expands Animal Health Solutions Business in Asia
4. Hospira Expands Board of Directors
5. Sidec AB Expands Into New Offices
6. Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO
7. SAFC Hitech(TM) Expands Sheboygan Facility With State-of-the-Art Manufacturing Cleanroom
8. Quintiles Consulting Business Expands
9. REVISED: BrainCells Inc. Expands Series B Financing to $50 Million
10. BrainCells Inc. Expands Series B Financing to $50 Million
11. Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology:
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
(Date:3/22/2016)... PROVO and SANDY, ... Screening Ontario (NSO), which operates the highest sample volume ... testing, and Tute Genomics and UNIConnect, leaders in clinical ... today announced the launch of a project to establish ... testing panel. NSO has been contracted ...
Breaking Biology News(10 mins):